[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100570197":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":26,"centralContacts":27,"locations":26,"responsibleParty":37,"collaborators":26,"id":39,"slug":26,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":26,"eligibilityCriteria":44,"healthyVolunteers":45,"sex":46,"minAge":47,"maxAge":48,"enrollmentInfo":49,"targetDuration":26,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":59,"overallStatus":64,"whyStopped":26,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":26},{"fullName":5,"class":6},"Universidad Austral de Chile","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A control. Ibuprofen","ACTIVE_COMPARATOR","Ibuprofen 400mg tablets, 1 every 8 hours for 3 days will be administered for post-surgical pain.",[13],"Drug: meloxicam 7,5mg",{"label":15,"type":10,"description":16,"interventionNames":17},"Group B experimental. Meloxicam","Meloxicam 7.5mg tablets, 1 every 12 hours for 3 days will be administered for post-surgical pain.",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","meloxicam 7,5mg","Comparison of analgesic efficacy of Meloxicam Vs Ibuprofen",[9,15],[25],"ibuprofen 400mg",null,[28,33],{"name":29,"role":30,"phone":31,"phoneExt":26,"email":32},"Carla C Bertran, DDS","CONTACT","56632228028","carlabertran@yahoo.com",{"name":34,"role":30,"phone":35,"phoneExt":26,"email":36},"Ruth R Falcón","56 940376396","ruth.falcon@alumnos.uach.cl",{"type":38,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100570197",false,"NCT06704113","Meloxicam Versus Ibuprofen for Pain Control After Third Molar Exodontia in Adult Patients","Analgesic Efficacy of Meloxicam Versus Ibuprofen for Pain Control After Third Molar Extraction in Adult Patients: Randomized Clinical Trial","Inclusion Criteria:\n\nMaxillary or mandibular third molar with semi or fully erupted crown.\n\nExclusion Criteria:\n\nPatients with Systemic pathologies. Presence of third molar localized infection. Completely included third molar crown. Periodontal compromise. Pregnant or breastfeeding women. Patients with hypersensitivity to NSAIDs. Patients with a history of drug abuse. Patients who had taken any drug in the previous 24 hours. Intervention (exodontia) time longer than 45 minutes.",true,"ALL","18 Years","59 Years",{"count":50,"type":51},68,"ESTIMATED","INTERVENTIONAL",[54],"PHASE4","Third molar extraction is a common dental procedure, offently related with pain and swelling. The purpose of this study is to evaluate if Meloxicam has a better effect relieving pain after the extraction than Ibuprofen, one of the most common pain relieving drugs administered after this procedure.",[57,58],"Dental Pain","Sensation Disorders",[60,61,62,63],"Tooth Extraction","Molar, Third","Meloxicam","Ibuprofen","NOT_YET_RECRUITING","2024-11-22",{"date":67,"type":68},"2024-11-25","ACTUAL",{"date":70,"type":51},"2024-12-15",{"date":72,"type":51},"2025-01-20",{"name":5,"class":6}]